Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

More Evidence Dexamethasone Speeds Recovery in Kids with Septic Arthritis

Will Boggs, MD  |  September 11, 2015

NEW YORK (Reuters Health)—Adding to earlier evidence, a new study finds kids with septic arthritis who are treated with dexamethasone recover faster.

“We expected these results based on our previous randomized double-blind controlled study,” Dr. Itay Fogel from Schneider Children’s Medical Center of Israel and Tel Aviv University told Reuters Health by email. “However, the present study that included a large number of children is an important reassurance that the principle of combining antibiotic treatment with anti-inflammatory medication is of benefit to the treatment of children suffering from septic arthritis.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In an earlier randomized trial, Dr. Fogel’s team showed that dexamethasone as adjuvant therapy brought significant clinical and laboratory improvement, shortened the duration of hospitalization, and accelerated recovery in children with septic arthritis.

Their current retrospective study sought to evaluate the same approach in children with septic arthritis outside a randomized controlled trial.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Ninety children were treated with antibiotics alone, and 26 patients received antibiotics plus intravenous dexamethasone 0.15 mg/kg every six hours for 16 consecutive doses.

Children treated with antibiotics plus dexamethasone had significantly shorter duration of fever (2.3 vs. 3.9 days), shorter time to full recovery (6.3 vs. 10.0 days), shorter time to a decrease in C-reactive protein level to below 1 mg/dL (5.3 vs. 8.4 days), shorter duration of intravenous antibiotic treatment (7.1 vs. 11.4 days), and shorter hospital stay (8.0 vs. 10.7 days).

The total duration of antibiotic therapy did not differ significantly between the groups, the researchers report in Pediatrics, online Sept. 7.

“The new principle of adding corticosteroids to antibiotic should be carefully studied and evaluated for other infectious diseases in children such as pneumonia, pyelonephritis and bacterial lymphadenitis,” Dr. Fogel said.

He added, “We should be cautious in generalizing the efficacy of this treatment for all cases of septic arthritis. Our study did not include cases with MRSA as the pathogen of septic arthritis. Further studies that include cases with community-acquired MRSA should be performed in North America before it becomes the standard of care.”

“Further studies are needed to examine possible long-term sequelae in children treated with antibiotics with or without adjunctive dexamethasone,” the researchers note.

Share: 

Filed under:ConditionsDrug Updates Tagged with:Childrendexamethasoneseptic arthritis

Related Articles
    The Patient's Choice

    When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

    September 7, 2016

    Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

    Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

    February 16, 2021

    A team of healthcare practitioners and researchers, spearheaded by the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN) and the ACR, has developed updated evidence-based clinical practice guidelines for the prevention, diagnosis and treatment of Lyme disease. The 2020 guidelines cover a wide variety of Lyme disease manifestations, including Lyme arthritis. Linda…

    Case Report: CPPD Presenting as Pseudosepsis

    September 6, 2022

    Calcium pyrophosphate crystal deposition disease (CPPD) is an arthritis caused by the accumulation of calcium pyrophosphate crystals. Despite a prevalence of 4–7% among the adult population in Europe and the U.S., it has remained a relatively under-recognized disease owing to its many clinical presentations.1 CPPD may cause an acute mono/oligoarthritis, which may mimic gout or…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences